Retraction
Nanoscale drug delivery strategies for therapy of ovarian cancer: conventional vs targeted
Paper Information
Record ID:
27334
Author(s):
Publication Date:
October 18, 2019
Retraction Date:
April 06, 2021
(4.6 years years ago)
Subjects:
Institutions:
- Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida, India
- College of Pharmacy, University of South Florida Health, Tampa, FL, USA
- Faculty of Pharmacy, University of Airlangga, Surabaya, Indonesia
- TERI-Deakin Nanobiotechnology Centre, The Energy and Resources Institute (TERI), Gual Pahari, TERI Gram, Gurugram, India
- Department of Pharmaceutical Sciences, Dr H.S. Gour University, Sagar, India
Country:
🇮🇳 IndiaArticle Type:
Publisher:
Taylor and Francis
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1080/21691401.2021.1899448Citations (29)
29
Total Citations14
Post-Retraction(48.3%)
15
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
8
Within 1 year
3
After 2+ years
975
Days since retraction (latest)
Engineering Extracellular Vesicles Mimetics for Targeted Chemotherapy of Drug-Resistant Ovary Cancer
Xiaoguang Liu, Guangquan Liu, Yinghua Mao et al. (10 authors)
Nanomedicine
Published: Dec 2023
7 citations
7 citations
975 days after retraction
Nano-drug delivery systems based on biodegradable polymers for the therapy of gynecological malignancies
Keer Jin, Hanxue Zhang, Yuwei Yang et al. (4 authors)
International Journal of Polymeric Materials
Published: Sep 2023
1 citation
1 citation
906 days after retraction
A Comprehensive Review on Current Treatments and Challenges Involved in the Treatment of Ovarian Cancer
Saika Saman, Nimisha Srivastava, Mohd Yasir et al. (4 authors)
Current Cancer Drug Targets
Published: Aug 2023
9 citations
9 citations
875 days after retraction
Engineered nanostructures: an introduction
Megha A. Deshmukh, Hanuman N. Thorat, Mahendra D. Shirsat et al. (4 authors)
Elsevier eBooks
Published: Jan 2023
2 citations
2 citations
635 days after retraction
MULTIFUNCTIONAL NANOSYSTEMS BASED ON TWO FLUORESCENT DYES, DOXORUBICIN AND CURCUMIN
M. I. Kaniuk
Biotechnologia Acta
Open Access
Published: Dec 2022
1 citation
1 citation
633 days after retraction
Opto-electronic Properties of Small ZnO\(_2\) Nanoparticles: First-Principles Insights
Nguyễn Thành Tiên, Minh Triết Đặng, Phạm Thị Bích Thảo
Communications in Physics
Open Access
Published: Jul 2022
455 days after retraction
mPEG-PDLLA Micelles Potentiate Docetaxel for Intraperitoneal Chemotherapy in Ovarian Cancer Peritoneal Metastasis
Yumei Zhang, Shunli Wang, Xiaofan Duan et al. (8 authors)
Frontiers in Pharmacology
Open Access
Published: Apr 2022
8 citations
8 citations
365 days after retraction
In Vivo Fate of Nanoparticles Undergoing Macrophage Targeting
Anushka Tyagi, Atul Pathak, Yashwant Pathak et al. (4 authors)
Springer eBooks
Published: Jan 2022
2 citations
2 citations
270 days after retraction
Nanoparticles-Based Theranostics for Macrophage Targeting
Amisha Chauhan, Mahima Gupta, Anushka Tyagi et al. (5 authors)
Springer eBooks
Published: Jan 2022
1 citation
1 citation
270 days after retraction
Combination drug delivery approaches for cancer therapy
Gowtham Kenguva, Ravi Bandaru, Smruti Rekha Rout et al. (6 authors)
Elsevier eBooks
Published: Jan 2022
1 citation
1 citation
270 days after retraction
Engineered strategies to enhance tumor penetration of drug-loaded nanoparticles
Mohammad Souri, M. Soltani, Farshad Moradi Kashkooli et al. (4 authors)
Journal of Controlled Release
Published: Nov 2021
127 citations
127 citations
230 days after retraction
Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)<sub>2</sub> NS) for Ovarian Cancer Therapy
Muhammad Adeel, Salvatore Parisi, Matteo Mauceri et al. (10 authors)
ACS Omega
Open Access
Published: Oct 2021
14 citations
14 citations
196 days after retraction
Usage of Platinum Nanoparticles for Anticancer Therapy over Last Decade: A Review
Aditya Amrut Pawar, Jyotirmayee Sahoo, Aakash Verma et al. (5 authors)
Particle & Particle Systems Characterization
Published: Sep 2021
25 citations
25 citations
159 days after retraction
Long non-coding RNA SDCBP2-AS1 delays the progression of ovarian cancer via microRNA-100-5p-targeted EPDR1
Xiu Liu, Chanyuan Liu, Aijun Zhang et al. (7 authors)
World Journal of Surgical Oncology
Open Access
Published: Jul 2021
23 citations
23 citations
89 days after retraction
Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer
Fangyuan Guo, Nan Yu, Yunlong Jiao et al. (11 authors)
Drug Delivery
Open Access
Published: Jan 2021
24 citations
24 citations
95 days before retraction
Overcoming drug resistance in ovarian cancer: Chemo-sensitizing agents, targeted therapies
Santoshi Muppala
Elsevier eBooks
Published: Jan 2021
95 days before retraction
Future perspectives and new directions in chemosensitizing activities to reverse drug resistance in gynecologic cancers: Emphasis on challenges and opportunities
Ishna Sharma, Nathan Hannay, Swathi Sridhar et al. (5 authors)
Elsevier eBooks
Published: Jan 2021
1 citation
1 citation
95 days before retraction
Synthesis of nanomedicine hydrogel microcapsules by droplet microfluidic process and their pH and temperature dependent release
Ran Liu, Qiong Wu, Xing Huang et al. (8 authors)
RSC Advances
Open Access
Published: Jan 2021
25 citations
25 citations
95 days before retraction
Cisplatin-loaded albumin nanoparticle and study their internalization effect by using β-cyclodextrin
Rahul Tiwari, K. Viswanathan, Vishal Gour et al. (5 authors)
Journal of Receptors and Signal Transduction
Published: Sep 2020
12 citations
12 citations
209 days before retraction
Visible Light-Activated Water-Soluble Platicur Nanocolloids: Photocytotoxicity and Metabolomics Studies in Cancer Cells
Federica De Castro, Viviana Vergaro, Michele Benedetti et al. (9 authors)
ACS Applied Bio Materials
Open Access
Published: Sep 2020
17 citations
17 citations
211 days before retraction
Perspectives in Breast and Ovarian Cancer Chemotherapy by Nanomedicine Approach: Nanoformulations in Clinical Research
Cristina Martín‐Sabroso, Ana Isabel Fraguas‐Sánchez, Rafaela Raposo-González et al. (4 authors)
Current Medicinal Chemistry
Published: Aug 2020
12 citations
12 citations
229 days before retraction
Cholic Acid-Functionalized Mesoporous Silica Nanoparticles Loaded With Ruthenium Pro-drug Delivery to Cervical Cancer Therapy
Wenxin Zhou
Journal of Inorganic and Organometallic Polymers and Materials
Published: Aug 2020
9 citations
9 citations
232 days before retraction
8-Hydroxyquinoline functionalized covalent organic framework as a pH sensitive carrier for drug delivery
Yutao Jia, Lina Zhang, Binnan He et al. (6 authors)
Materials Science and Engineering C
Published: Jun 2020
59 citations
59 citations
280 days before retraction
Ефект етил 2-(хіназолін-4-іл-аміно)-4,5,6,7-тетрагідробензо[b]тіофен-3карбоксилат гідрохлориду на ДНК, РНК, білки хроматину та вміст небілкових і пов’язаних з білками SH-груп у саркомі 45 і незмінених тканинах шкіри щурів
Л. Б. Бондаренко, Т. А. Карацуба, О. О. Хавич et al. (9 authors)
Pharmacology and Drug Toxicology
Open Access
Published: Jun 2020
307 days before retraction
PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment
Ana Isabel Fraguas‐Sánchez, Ana Isabel Torres‐Suárez, Marie Cohen et al. (8 authors)
Pharmaceutics
Open Access
Published: May 2020
77 citations
77 citations
332 days before retraction
Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells
Chang‐Hyun Kim, Tae Hoon Kang, Byoung Deok Kim et al. (9 authors)
International Journal of Pharmaceutics
Published: May 2020
22 citations
22 citations
337 days before retraction
Вплив 2-(3-аліл-4-оксо-3,4-дигідро-хіназолін- 2-іл-сульфоніл)-N-(2,6-дихлорфеніл)-цераміду на складові хроматину та стан антиоксидантної системи в саркомі 45 і незмінених тканинах шкіри щурів
Л. Б. Бондаренко, Т. А. Карацуба, О. О. Хавич et al. (9 authors)
Pharmacology and Drug Toxicology
Open Access
Published: Mar 2020
375 days before retraction
Ефект етил 2-(хіназолін-4-іламіно)-4,5,6,7тетрагідробензо[ b ]тіофен-3-карбоксилат гідрохлориду на ДНК, РНК, білки хроматину й показники стану антиоксидантної системи в карциномі Герена та незмінених тканинах матки щурів
Л. Б. Бондаренко, Т. А. Карацуба, О. О. Хавич et al. (9 authors)
Pharmacology and Drug Toxicology
Open Access
Published: Feb 2020
414 days before retraction
Вплив Іфітинібу на складові хроматину та стан антиоксидантної системи в карциномі Герена та незмінених тканинах матки
Л. Б. Бондаренко, Т. А. Карацуба
Pharmacology and Drug Toxicology
Open Access
Published: Jan 2020
459 days before retraction
Quick Stats
Total Citations:
29
Years Since Retraction:
4.6 years
Open Access:
Yes
Last Checked:
Jul 24, 2025